POM· Health Care› Pharmaceutical Retailers

POMDOCTOR LIMITED Class A

Stage 1 · Basing · week 1

As of Oct 22, 2026, POMDOCTOR is in Stage 1, the basing phase, now in its first week (since Oct 21, 2026). It closed at $2.03, 98.1% below its 52-week high and below its 200-day average, which is falling.

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. More about the company

$2.03

-32.56% today

$18.8M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is POM early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2025-10-08 → 2026-10-22

S? 41w

S4 12w

2025-10-082026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 41w → S4 12w → S1 1w current

Total tracked: 54 weeks across 3 stage runs.

POM among Pharmaceutical Retailers4th of 5 by relative strength

All 5 →

Stocks in Pharmaceutical Retailers ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	HITIHigh Tide Inc.	Stage 2 · wk 4	39	−2.4%
2	PETSPetMed Express, Inc.	Stage 4 · wk 30	21	−23.9%
3	SCNXScienture Holdings, Inc.	Stage 4 · wk 5	12	−61.8%
4	POMPOMDOCTOR LIMITED Class A	Stage 1 · wk 1	4	+153.8%
5	RDGTRidgetech, Inc.	Stage 4 · wk 30	2	−9.7%

vs 52W High

-98.1%

$0.53 lo$109.62 hi

98.1% below 52W high

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 1

1w13w26w

Week 1, early base

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

-33.5%

200 DMA: $3.05 · sloping down

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

14.24x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+153.8%

+185.9%

-71.6%

YTD

-65.4%

-97.4%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S1

Wk 1 · Vol 14.24x

2026-10-21S14→1

Wk 1 · Vol 1394.27x

2026-10-20S4

Wk 13 · Vol 1.22x

2026-10-19S4

Wk 12 · Vol 2.51x

2026-10-16S4

Wk 12 · Vol 0.53x

2026-10-15S4

Wk 12 · Vol 0.36x

2026-10-14S4

Wk 12 · Vol 0.45x

2026-10-13S4

Wk 12 · Vol 2.48x

2026-10-12S4

Wk 11 · Vol 0.48x

2026-10-09S4

Wk 11 · Vol 1.72x

2026-10-08S4

Wk 11 · Vol 1.30x

2026-10-07S4

Wk 11 · Vol 1.29x

Moving averages & range

50 DMA

$0.92

200 DMA

$3.05

52W High

$109.62

52W Low

$0.53

5D Low

$0.53

Resistance levels (recent highs)

20d High

$3.01

60d High

$3.01

120d High

$9.56

250d High

$109.62

Next resistance

+48.3%

to 20d High

Dividend Yield

0.00%

P/B -0.7

POMDOCTOR: quick answers

What stage is POMDOCTOR in?

As of Oct 22, 2026, POMDOCTOR (POM) is in Stage 1, the basing phase. It entered Stage 1 on Oct 21, 2026 and is in its first week there. What the four stages mean

Is POMDOCTOR in an uptrend?

Not yet. POMDOCTOR is in Stage 1, a base that can come before an uptrend. It trades 33.5% below its 200-day average, which is falling.

How far is POMDOCTOR from its 52-week high?

POMDOCTOR closed at $2.03 on Oct 22, 2026, 98.1% below its 52-week high of $109.62. Its 52-week low is $0.53.

How has POMDOCTOR performed over the past year?

As of Oct 22, 2026, POMDOCTOR is down 97.4% over the past year and down 65.4% so far in 2026.

Which sector and industry is POMDOCTOR in?

POMDOCTOR is in the Pharmaceutical Retailers industry, part of the Health Care sector.

About this companyHealth Care· Pharmaceutical Retailers

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.